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Abstract
The rising medical costs associated with cancer have led to considerable financial hardship for 
patients and their families in the United States. Using data from the LIVESTRONG 2012 survey 
of 4,719 cancer survivors ages 18–64, we examined the proportions of survivors who reported 
going into debt or filing for bankruptcy as a result of cancer, as well as the amount of debt 
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incurred. Approximately one-third of the survivors had gone into debt, and 3 percent had filed for 
bankruptcy. Of those who had gone into debt, 55 percent incurred obligations of $10,000 or more. 
Cancer survivors who were younger, had lower incomes, and had public health insurance were 
more likely to go into debt or file for bankruptcy, compared to those who were older, had higher 
incomes, and had private insurance, respectively. Future longitudinal population-based studies are 
needed to improve understanding of financial hardship among US working-age cancer survivors 
throughout the cancer care trajectory and, ultimately, to help stakeholders develop evidence-based 
interventions and policies to reduce the financial hardship of cancer.
The cost of cancer care in the United States has become a significant social and public health 
issue. Cancer care costs are rising at two to three times the rate of other health care costs1 
and are projected to continue increasing over the next decade.2 Novel cancer therapy agents 
can cost more than $60,000 for a month of treatment,3 and the average monthly cost per 
agent has more than doubled over the past decade, to $10,000.1 Health insurers have been 
adopting strategies to control their costs—for example, by increasing patient cost sharing 
through higher premiums, deductibles, copayments, coinsurance, and other out-of-pocket 
expenses.4
Average out-of-pocket expenses for an individual are $1,107 in the first year after a cancer 
diagnosis and $747 annually thereafter.5 Some cancer patients must pay $10,000 in out-of-
pocket expenses before comprehensive insurance coverage begins, while other patients reach 
their annual out-of-pocket maximum in just the first month of treatment.1 Consequently, an 
increasing number of patients experience financial hardship following a cancer diagnosis, 
including accruing large medical debts, exhausting assets and savings to pay for treatment, 
and filing for bankruptcy.6–9
Previous research has shown that approximately 30 percent of cancer survivors report 
experiencing financial hardship,9–11 as well as bankruptcy rates that are 2.5 times higher 
than those of people without a history of cancer.7 The risk of financial hardship and 
bankruptcy associated with cancer is higher among the working-age population (ages 18–64) 
than among the elderly
.
6,7,9,12–14
Working-age cancer survivors may face unique challenges, given that the majority of them 
rely on employment as the primary source of health insurance. A cancer diagnosis and 
subsequent treatment may prevent them from working or lead to disabilities that limit their 
ability to perform work-related tasks.15–25 Additionally, financial hardship resulting from 
cancer has been associated with forgoing or delaying the receipt of medical care, both care 
related to cancer and unrelated care.6,26 Treatment nonadherence6,10,27 and difficulties 
paying for basic necessities such as utilities and mortgages28–30 may have a negative effect 
on health outcomes.
Other studies have compared overall medical and out-of-pocket expenses of working-age 
cancer survivors with those of people without a history of cancer to control for the potential 
impact of other medical conditions, instead of having directly assessed financial hardship 
due to cancer.5,31,32 In this study we used data on financial hardship reported in a web-based 
survey of working-age cancer survivors conducted by the LIVE-STRONG Foundation in 
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2012. We assessed the proportion of working-age cancer survivors who reported that they or 
their families had gone into debt (respondents also gave the amount of debt incurred) and the 
proportion who reported having filed for bankruptcy because of cancer, its treatment, or the 
lasting effects of that treatment.
By estimating the prevalence of debt and bankruptcy among working-age cancer survivors, 
our study may lead to a better understanding of the extent to which financial hardship from 
cancer disproportionately affects working-age people, highlighting the potential need for 
financial protection assistance (such as financial counseling, payment assistance, or 
medication assistance programs). Importantly, while our findings address a significant gap in 
evidence, longitudinal population-based studies are warranted to improve the understanding 
of the magnitude and extent of financial hardship among cancer survivors and their families.
Study Data And Methods
Data Source And Study Population
This study used data from the 2012 LIVESTRONG Survey. The online survey was designed 
to elucidate the needs of individuals diagnosed with cancer, both during and after their 
cancer treatment. Survey respondents were recruited through several channels, including the 
LIVESTRONG Foundation constituency (donors, participants in events or programs, 
advocates, and others), Facebook, Twitter, and partnerships with national and community-
based organizations.
We excluded respondents who did not have a personal history of cancer (caregivers, family 
members, and other respondents who had not survived cancer themselves), those who 
resided outside the United States or a US territory, and those who were age sixty-five or 
older. Our study sample consisted of 4,719 working-age adults with a previous diagnosis of 
cancer. Respondents came from all fifty states, the District of Columbia, Puerto Rico, and 
the US Virgin Islands.
Measures
The 2012 LIVESTRONG Survey used the same measures to assess financial hardship 
among cancer survivors as did the 2011 Medical Expenditure Panel Survey (MEPS) 
Experiences with Cancer Survivorship Supplement.33 All questions in the MEPS 
supplement were developed using cognitive testing of a representative group of cancer 
survivors. More details about the survey design, developmental cognitive testing, and 
content are available elsewhere.33,34
The primary outcomes in our analysis were participants’ responses to the following 
questions: “Have you or has anyone in your family had to borrow money or go into debt 
because of your cancer, its treatment, or the lasting effects of that treatment?” and “Did you 
or anyone in your family ever file for bankruptcy because of your cancer, its treatment, or 
the lasting effects of that treatment?” We also analyzed participants’ responses to other 
measures of financial hardship, including the amount of money borrowed and the size of the 
debt incurred; worry about paying large medical bills; having to make other financial 
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sacrifices; and types of out-of-pocket expenses (for the LIVESTRONG survey items used in 
our analysis, see the online Appendix).35
Demographic information included age, sex, race/ethnicity, educational attainment, marital 
status, annual household income, and employment and insurance status. Insurance status was 
coded into four categories: private (private, employer-sponsored, or military insurance), 
public (coverage through a federal program such as Medicare or Medicaid), uninsured, and 
other (including respondents who said they preferred not to answer or did not know and 
those who did not answer). Cancer-related information included cancer type, time since first 
cancer diagnosis, and time since last cancer treatment.
Statistical Analysis
Descriptive statistics were calculated for all demographic characteristics, cancer-related 
characteristics, and outcome measures. For each of the outcomes—going into debt and 
bankruptcy—demographic and cancer-related characteristics with an alpha value of ≤0.20 in 
bivariate logistic regression analysis were retained in the final multivariable logistic 
regression models. In the final multivariable models, a two-sided p value less than 0.05 was 
considered significant. Separate logistic regression models were used for each outcome. 
Analyses of the amount of debt incurred and sources of out-of-pocket spending were limited 
to participants who reported going into debt. All analyses were performed using Stata, 
version 13.1.
Limitations
This study provides valuable information about financial hardship among working-age 
cancer survivors. However, several limitations should be noted. First, cancer survivors were 
recruited from multiple sources, and thus our study was not population based. Compared to 
a nationally representative sample of cancer survivors from MEPS,14,33 survey participants 
were more likely to be privately insured and had higher income levels and educational 
attainment. In addition, all participants needed to have access to the Internet to complete the 
survey. Because many of these factors are associated with a reduced risk of financial 
hardship,5–7‘15‘25 our results may underestimate the level of financial hardship among US 
workingage cancer survivors. Nonetheless, a high proportion of our sample population was 
young and recently diagnosed with their first cancer, factors associated with increased risk of 
financial hardship.36
Second, our study data were self-reported and subject to recall bias and misclassification. 
Third, we did not have information on specific clinical characteristics, including stage of 
cancer at diagnosis, presence of comorbid conditions, and whether subsequent cancers 
actually represented a recurrence for survivors reporting two or more cancers.
Fourth, small sample sizes of survivors with specific cancers (such as breast, lung, and 
prostate cancer) precluded us from reporting results for each cancer type. Accordingly, 
ongoing evaluation of financial hardship by cancer type will be important for future 
research. Fifth, given the cross-sectional study design, we were not able to determine the 
underlying cause of the financial hardship of cancer attributable to specific characteristics 
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(for example, whether the costs of care or loss of employment caused the financial 
hardship).
Sixth, our analysis was limited to US cancer survivors. The paucity of evidence on the 
financial hardship of cancer among survivors in other countries suggests the need for future 
research in this area to assess access to affordable health care. Lastly, we did not have 
detailed information on the type of bankruptcy filed—involuntary (filed under Chapter 7 of 
the US Bankruptcy Code) or voluntary (filed under Chapter 13).
Study Results
The majority of cancer survivors in our study were non-Hispanic white (88 percent), female 
(67 percent), married (69 percent), employed full time (54 percent), and privately insured 
(85 percent) (Exhibit 1). Sixty-two percent had a bachelor’s or advanced degree, and 42 
percent had an annual household income of at least $81,000. Seventy-five percent reported 
having been diagnosed with only one cancer. Sixty percent had received their first cancer 
diagnosis within the past five years, and 56 percent had had their last treatment within the 
past five years.
Sixty-four percent reported worrying about having to pay large bills related to their cancer, 
its treatment, or the treatment’s lasting effects (Exhibit 2). Thirty-four percent reported that 
they or someone in the family had gone into debt because of cancer, and 3 percent said that 
they or their families had filed for bankruptcy as a result of cancer. Forty percent reported 
making other financial sacrifices.
Among the subset of survivors who reported that they or someone in their family had gone 
into debt, 87 percent said that they had worried about paying large bills related to cancer, 
and 9 percent reported that they or someone in their family had filed for bankruptcy as a 
result of their cancer. Sixty-eight percent made other financial sacrifices. Ninety-four percent 
had out-of-pocket spending on medical expenses, and 60 percent had such spending for 
transportation (Exhibit 3).
Of the 1,583 cancer survivors who reported that they or someone in their family had gone 
into debt, 1,558 reported the amount of debt incurred. Among this sample, 45 percent 
incurred less than $10,000, 30 percent incurred $10,000–$24,999, 12 percent incurred 
$25,000–$49,999, and 13 percent incurred $50,000 or more (for more details on the amounts 
of debt, see the Appendix).35
Survivors ages 18–44 or 45–54 were significantly more likely to go into debt than those ages 
55–64 (Exhibit 4). Also significantly more likely to go into debt were people who had lower 
annual incomes, compared to those in the highest annual income category ($81,000 or 
more); survivors who were unemployed, compared to those employed full time; people who 
reported two or more cancer diagnoses, compared to those with only one cancer diagnosis; 
and survivors who had public insurance such as Medicaid or who were uninsured, compared 
to those with private insurance.
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Filing for bankruptcy because of cancer was also significantly associated with younger age, 
lower annual household income, being unemployed, having public insurance, and having 
two or more cancer diagnoses (Exhibit 4). In addition, time since last cancer treatment was 
associated with bankruptcy: People whose last cancer treatment was more than two years in 
the past were significantly more likely to file for bankruptcy, compared to survivors in their 
first year of treatment.
Discussion
Using data from the LIVESTRONG 2012 survey, we found evidence of both material and 
psychological financial hardship among working-age cancer survivors, manifested as debt, 
bankruptcy, and worry about paying large medical bills. The extent of financial hardship was 
more pronounced for survivors who reported that they or their families had gone into debt 
because of cancer: Nine percent of these survivors reported filing bankruptcy, and 55 percent 
incurred debt of $10,000 or more. Working-age survivors (and their families) at greater risk 
for debt and bankruptcy included those who were younger, unemployed, and uninsured or 
publicly insured, compared to those who were older, employed full time, and those with 
private insurance; and those who had a lower annual household income and two or more 
cancer diagnoses, compared to those with a higher income and only one cancer diagnosis.
The results of this study underscore the potential financial implications of cancer and the 
need for population-based surveys to further evaluate the financial hardship of cancer, its 
treatment, and the lasting effects of that treatment.
Affordability Of Care
Given that the costs of health care are increasing faster than household incomes in the 
United States,37 there is growing concern among patients, providers, and other stakeholders 
about the affordability of care.38 This is particularly so in the case of the working-age cancer 
survivor population, whose mean annual health care expenditures ($17,170 for cancer 
survivors within one year of diagnosis and $9,369 for cancer survivors after the first year) 
far exceed those of the working-age population with no history of cancer ($3,611).5
Furthermore, studies indicate that the proportion of working-age US households facing 
financial hardship as a result of health care expenses remains high, regardless of insurance 
status.37,39,40 In 2011 nearly one in five workingage Americans lived in families whose 
combined out-of-pocket spending on medical expenses and insurance premiums was 10 
percent or more of the family income.41 If this trend continues, such high out-of-pocket 
spending may become the primary driver of financial hardship for working-age cancer 
survivors and may lead to higher levels of debt and bankruptcy than this study found.
Our estimates of bankruptcy filing among working-age cancer survivors are consistent with 
the work of Scott Ramsey and colleagues,7 who reported that 2.2 percent of people with a 
cancer diagnosis in western Washington State filed for bankruptcy following the diagnosis, 
and the work of Karen Meneses and colleagues,12 who found that 3.1 percent of breast 
cancer patients declared bankruptcy within six months after treatment. Although the 
proportion of cancer survivors filing for bankruptcy across studies is relatively low, it is 
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important to recognize that bankruptcy caused by medical expenses is an indication of 
extreme financial hardship.
To help prevent bankruptcy, people should receive help identifying sources of financial 
assistance and information that can be used in decision making about the costs of care 
shortly after diagnosis instead of long after treatment, when fewer medical debt assistance 
options exist. Given that illness or medical bills contribute to approximately 62 percent of all 
bankruptcies,13,42 our findings help highlight the issue of medical debt in the United States 
and the importance of helping patients understand the costs of care at each stage of their 
disease experience.
A recent population-based study of US cancer survivors using MEPS data showed that 
approximately 13 percent of working-age survivors reported ever borrowing money or going 
into debt, 2.3 percent said that they had ever filed for bankruptcy, and 32 percent reported 
having worried about medical bills related to their cancer.14 In contrast, we found higher 
prevalence of debt, bankruptcy, and worry about paying large medical bills because of 
cancer.
Our sample was larger than that in the previous study, which allowed us to evaluate patient 
factors associated with medical debt. Although our study population had high educational 
attainment and high income levels—factors associated with reduced risk of financial 
hardship— we found that other characteristics of the population (such as more recent cancer 
diagnosis and younger age) were associated with greater risk of financial hardship, 
compared to survivors who had been diagnosed less recently or who were older.9,10,28 
Together, these studies add valuable information to a growing body of evidence that 
highlights specific components of both the material (debt, bankruptcy, and inability to cover 
medical costs) and psychological (worry about paying medical bills) aspects of financial 
hardship among cancer survivors.
While documenting the financial hardship that working-age survivors experience is a critical 
step, the current level of evidence is insufficient to guide the development of specific 
interventions. Future longitudinal population-based studies will be important in providing a 
clear picture of the multiple aspects of financial hardship and its impact on health outcomes 
among working-age cancer survivors. For instance, there is a need for more information 
about the occurrence and progression of financial hardship and about the relationship among 
survivors’ financial, employment, and insurance status from the time of cancer diagnosis 
through the completion of treatment and beyond.7
Studies that follow working-age cancer patients over time will provide insights into what 
kinds of assistance are needed most, when, and by whom. Additionally, studies on the 
financial hardship that arises from specific cancer types or recurrent disease are warranted to 
improve understanding of the variation across populations of survivors. The findings from 
these studies will help focus efforts to prevent financial hardship resulting from cancer on 
the level—for example, the patient, provider, payer, or system level—at which interventions 
and policies may be most effective.
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IMPACT OF THE AFFORDABLE CARE ACT
The Affordable Care Act (ACA) was designed to increase access to health insurance and 
protect people from high or unexpected medical care expenses.37,41 Furthermore, the ACA 
contains provisions that may assist working-age people diagnosed with cancer, such as the 
elimination of annual and lifetime limits on coverage for essential health benefits, caps on 
out-of-pocket spending for in-network medical services, and insurance premium tax credits 
and cost-sharing subsidies for individuals and families who meet eligibility requirements.
There is evidence of significant out-of-pocket burden for cancer survivors prior to the ACA,
6,43,44
 even among survivors who were insured. Thus, these ACA provisions may help 
reduce the likelihood of financial hardship by limiting out-of-pocket expenses. Additionally, 
for those populations that our study found to be at greatest risk of financial hardship from 
cancer, including survivors with low household incomes and without insurance, the ACA 
may improve insurance availability through both expanded eligibility for Medicaid in 
selected states and premium tax credits in the health insurance Marketplaces.45
However, states’ decisions about whether or not to expand eligibility for Medicaid may 
affect the number of cancer survivors who could benefit.45 Moreover, most working-age US 
adults obtain health insurance through their employers and often do not meet eligibility 
requirements for benefiting from the ACA cost-containing provisions.41 Consequently, it 
will be important for future researchers to assess the impact of the ACA on barriers to access 
to care, costs of care for cancer survivors, and the associated financial hardship of cancer.
Identifying the extent to which the rising costs of care lead to financial hardship is essential 
for evaluating their impact on care quality. Efforts such as those related to the American 
Society of Clinical Oncology’s Value in Cancer Care initiative have been made to help 
patients, providers, payers, and other stakeholders understand the importance of recognizing 
the implications of cost, understand the various costs associated with care, and integrate 
information about cost into treatment discussions to optimize medical decision making.46
Studies indicate that financial hardship may have a negative impact on individuals’ access to 
care, quality of care, and health outcomes38 and that there are associations between financial 
hardship and decreased initiation of cancer therapy, delays in therapy initiation, and 
discontinuation of recommended therapy regimens.47–50 Furthermore, treatment delays and 
nonadherence can lead to the progression of disease or increased disease severity, adverse 
events, premature death, and increased overall health care expenditures (such as those 
caused by increased use of hospitals, particularly emergency departments).49,51 Thus, it is 
imperative that the costs of cancer care be balanced with the ability to access care that is 
high quality and clinically beneficial, particularly because patients must make decisions 
about care that could lead to substantial financial hardship for themselves and their families.
Conclusion
Our study provides evidence of the financial hardship that working-age cancer survivors and 
their families may experience. We identified characteristics of those who may be at greatest 
financial risk. The substantial proportion of cancer survivors who reported going into debt 
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and the high amount of debt incurred raise important questions about the financial well-
being of working-age individuals diagnosed with cancer.
Essential to reducing the financial hardship caused by cancer is early education of patients—
at the time of diagnosis—so that they can engage in conversations with their families and 
clinicians to optimally manage the physical, emotional, and financial impacts of cancer. 
Improving our understanding of financial hardship among cancer survivors, including both 
material and psychological effects, will provide stakeholders with the information required 
to identify those individuals who are most vulnerable and to develop evidence-based 
interventions and policies to help reduce the potential for financial hardship.■
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64% Worried
Among respondents, 64 percent reported being worried about having to pay large bills 
related to their cancer.
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EXHIBIT 1. 
Characteristics Of 4,719 Cancer Survivors Ages 18–64, 2012
SOURCE Authors’ analysis of data from the LIVESTRONG 2012 survey. NOTE Percentages 
may not sum to 100 because of rounding. aPeople who were single, divorced, widowed, or 
separated; who preferred not to answer; and for whom answers were missing. bPeople who 
preferred not to answer or said they did not know. cPrivate, employer-based, or military 
insurance. dDiagnoses of one or more subsequent primary cancers or of recurrence of the 
first primary cancer.
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EXHIBIT 2. 
Working-Age Cancer Survivors’ Responses To Survey Questions About Worry And 
Sacrifices, 2012
SOURCE Authors’ analysis of data from the LIVESTRONG 2012 survey. NOTES The numbers 
and percentages presented are those of the participants who responded “yes” to each 
question. For all survivors, N = 4,719. For survivors who reported going into debt, n = 
1,583. aSurvey question included the phrase “because of your cancer, its treatment, or the 
lasting effects of that treatment?”
Banegas et al. Page 14
Health Aff (Millwood). Author manuscript; available in PMC 2018 July 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
EXHIBIT 3. 
Types Of Out-Of-Pocket Spending Among Working-Age Cancer Survivors Who Reported 
Borrowing Money Or Going Into Debt Because Of Cancer, 2012
SOURCE Authors’ analysis of data from the LIVESTRONG 2012 survey. NOTES The 
percentages presented are those of the 1,583 participants who responded yes to the question, 
“Have you or has anyone in your family had to borrow money or go into debt because of 
your cancer, its treatment, or the lasting effects of that treatment?” and who had valid 
responses to the question, “Because of your cancer, its treatment, or the lasting effects of 
that treatment, did you have any out-of-pocket costs in the following categories?” Categories 
are not mutually exclusive. “Medical expenses” include physician copayments, medications, 
and durable medical equipment.
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EXHIBIT 4. 
Working-Age Cancer Survivors’ Risk Factors For Borrowing Money, Going Into Debt, And 
Bankruptcy, By Various Characteristics, 2012
SOURCE Authors’ analysis of data from the LIVESTRONG 2012 survey. NOTES The exhibit 
shows the results of the final adjusted regression models. Associations between the two 
outcomes (borrowing money or going into debt and filing for bankruptcy) are based on the 
4,504 participants who had valid values for each variable included in the final model. A 
version of this exhibit including 95% confidence intervals can be found in the Appendix (see 
Note 35 in text). Significance refers to the difference from the reference category. aFor the 
analyses, annual household income was recategorized as shown in the exhibit. bPeople who 
preferred not to answer or said they did not know. cPrivate, employer-based, or military 
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insurance. dDiagnoses of one or more subsequent primary cancers or of recurrence of the 
first primary cancer. **p < 0.05 ***p < 0.001
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